435 related articles for article (PubMed ID: 17373882)
1. The 5-HT3 receptor as a therapeutic target.
Thompson AJ; Lummis SC
Expert Opin Ther Targets; 2007 Apr; 11(4):527-40. PubMed ID: 17373882
[TBL] [Abstract][Full Text] [Related]
2. 5-HT3 receptors.
Thompson AJ; Lummis SC
Curr Pharm Des; 2006; 12(28):3615-30. PubMed ID: 17073663
[TBL] [Abstract][Full Text] [Related]
3. Conformational Changes in the 5-HT
Munro L; Ladefoged LK; Padmanathan V; Andersen S; Schiøtt B; Kristensen AS
Mol Pharmacol; 2019 Dec; 96(6):720-734. PubMed ID: 31582575
[TBL] [Abstract][Full Text] [Related]
4. Therapeutics of 5-HT3 receptor antagonists: current uses and future directions.
Machu TK
Pharmacol Ther; 2011 Jun; 130(3):338-47. PubMed ID: 21356241
[TBL] [Abstract][Full Text] [Related]
5. Unbinding pathways of an agonist and an antagonist from the 5-HT3 receptor.
Thompson AJ; Chau PL; Chan SL; Lummis SC
Biophys J; 2006 Mar; 90(6):1979-91. PubMed ID: 16387779
[TBL] [Abstract][Full Text] [Related]
6. A triad of residues is functionally transferrable between 5-HT
Mosesso R; Dougherty DA
J Biol Chem; 2018 Feb; 293(8):2903-2914. PubMed ID: 29298898
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological and electrophysiological properties of the naturally occurring Pro391Arg variant of the human 5-HT3A receptor.
Kurzwelly D; Barann M; Kostanian A; Combrink S; Bönisch H; Göthert M; Brüss M
Pharmacogenetics; 2004 Mar; 14(3):165-72. PubMed ID: 15167704
[TBL] [Abstract][Full Text] [Related]
8. The molecular basis of the structure and function of the 5-HT3 receptor: a model ligand-gated ion channel (review).
Reeves DC; Lummis SC
Mol Membr Biol; 2002; 19(1):11-26. PubMed ID: 11989819
[TBL] [Abstract][Full Text] [Related]
9. Palonosetron-5-HT
Price KL; Lillestol RK; Ulens C; Lummis SC
ACS Chem Neurosci; 2016 Dec; 7(12):1641-1646. PubMed ID: 27656911
[TBL] [Abstract][Full Text] [Related]
10. Conformational transitions of the serotonin 5-HT
Polovinkin L; Hassaine G; Perot J; Neumann E; Jensen AA; Lefebvre SN; Corringer PJ; Neyton J; Chipot C; Dehez F; Schoehn G; Nury H
Nature; 2018 Nov; 563(7730):275-279. PubMed ID: 30401839
[TBL] [Abstract][Full Text] [Related]
11. The interactions of the 5-HT3 receptor with quipazine-like arylpiperazine ligands: the journey track at the end of the first decade of the third millennium.
Cappelli A; Butini S; Brizzi A; Gemma S; Valenti S; Giuliani G; Anzini M; Mennuni L; Campiani G; Brizzi V; Vomero S
Curr Top Med Chem; 2010; 10(5):504-26. PubMed ID: 20166948
[TBL] [Abstract][Full Text] [Related]
12. Visualising functional 5-HT
Abad IPL; Fam RL; Nguyen DT; Nowell CJ; Trinh PNH; Manallack DT; Freihat LA; Chakrabarti J; Jamil A; Exintaris B; Yaakob NS; Irving HR
Biomed Pharmacother; 2020 Dec; 132():110860. PubMed ID: 33059258
[TBL] [Abstract][Full Text] [Related]
13. 5-HT(3) receptors.
Lummis SC
J Biol Chem; 2012 Nov; 287(48):40239-45. PubMed ID: 23038271
[TBL] [Abstract][Full Text] [Related]
14. Binding interactions of antagonists with 5-hydroxytryptamine3A receptor models.
Maksay G; Bikádi Z; Simonyi M
J Recept Signal Transduct Res; 2003; 23(2-3):255-70. PubMed ID: 14626451
[TBL] [Abstract][Full Text] [Related]
15. Mapping spatial relationships between residues in the ligand-binding domain of the 5-HT3 receptor using a molecular ruler.
Nyce HL; Stober ST; Abrams CF; White MM
Biophys J; 2010 May; 98(9):1847-55. PubMed ID: 20441748
[TBL] [Abstract][Full Text] [Related]
16. X-ray structure of the mouse serotonin 5-HT3 receptor.
Hassaine G; Deluz C; Grasso L; Wyss R; Tol MB; Hovius R; Graff A; Stahlberg H; Tomizaki T; Desmyter A; Moreau C; Li XD; Poitevin F; Vogel H; Nury H
Nature; 2014 Aug; 512(7514):276-81. PubMed ID: 25119048
[TBL] [Abstract][Full Text] [Related]
17. Mapping the Orthosteric Binding Site of the Human 5-HT
Jack T; Leuenberger M; Ruepp MD; Vernekar SKV; Thompson AJ; Braga-Lagache S; Heller M; Lochner M
ACS Chem Neurosci; 2019 Jan; 10(1):438-450. PubMed ID: 30149702
[TBL] [Abstract][Full Text] [Related]
18. Serotonin 5-HT3 and 5-HT4 ligands: an update of medicinal chemistry research in the last few years.
Modica MN; Pittalà V; Romeo G; Salerno L; Siracusa MA
Curr Med Chem; 2010; 17(4):334-62. PubMed ID: 20015043
[TBL] [Abstract][Full Text] [Related]
19. Natural compounds boldine and menthol are antagonists of human 5-HT3 receptors: implications for treating gastrointestinal disorders.
Walstab J; Wohlfarth C; Hovius R; Schmitteckert S; Röth R; Lasitschka F; Wink M; Bönisch H; Niesler B
Neurogastroenterol Motil; 2014 Jun; 26(6):810-20. PubMed ID: 24708203
[TBL] [Abstract][Full Text] [Related]
20. The minimum M3-M4 loop length of neurotransmitter-activated pentameric receptors is critical for the structural integrity of cytoplasmic portals.
Baptista-Hon DT; Deeb TZ; Lambert JJ; Peters JA; Hales TG
J Biol Chem; 2013 Jul; 288(30):21558-68. PubMed ID: 23740249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
